Antepartum glucocorticoid therapy suppresses human placental xenobiotic and steroid metabolizing enzymes

Placenta

Volumn 21, Issue 2-3, 2000, Pages 241-246

  Paakki, P ^a   Kirkinen, P ^b   Helin, H L ^b   Pelkonen, O ^a   Raunio, H ^a   Pasanen, M ^a,c  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c NATIONAL AGENCY FOR MEDICINES   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

7 ETHOXYCOUMARIN DEETHYLASE; ANDROSTENEDIONE; AROMATASE; BETAMETHASONE; CORTICOSTEROID; CYTOCHROME P450; ETHOXYRESORUFIN DEETHYLASE; PLACENTA ENZYME; STEROID HORMONE; TESTOSTERONE; XENOBIOTIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DELIVERY; ENZYME ACTIVITY; FEMALE; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; NEONATAL RESPIRATORY DISTRESS SYNDROME; PLACENTA; PRIORITY JOURNAL; XENOBIOTIC METABOLISM;

EID: 0034053386     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1053/plac.1999.0471     Document Type: Article

References (32)

1. Albretsen C, Haukanes B-I, Aasland R, Kleppe K. Optimal conditions for hybridization with oligonucleotides: A study with myc -oncogene DNA probes. Anal Biochem. 170:1988;193-202.
2. Barbieri RL, Gochberg J, Ryan KJ. Nicotine, cotinine and anabasine inhibit aromatase in human trophoplast in vitro. J Clin Invest. 77:1986;1727-1733.
3. Burke MD, Thompson S, Elcombe CR, Halpert J, Haaparanta T, Mayer RT. Ethoxy-, pentoxy-and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450. Biochem Pharmacol. 34:1985;3337-3345.
4. Donato TM, Castell JV, Gomez-Lechon MJ. Effect of model inducers on cytochrome P450 activities of human hepatocytes in primary culture. Drug Metab Dispos. 23:1995;553-558.
5. Goodman Gilman A. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 1990;Pergamon Press, New York.
6. Graf R, Gossrau R, Frank HG. Placental toxicity in rats after administration of synthetic glucocorticoids. Anat Embryol. 180:1989;121-130.
7. Greenlee WF, Poland A. An improved assay of 7-ethoxycoumarin O-deethylase activity: Induction of hepatic enzyme activity in C57BL/6J and DBA/2J mice by phenobarbital, 3-methylcholanthrene and 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Pharmacol Exp Ther. 205:1978;596-605.
8. Hahn T, Graf R, Öney T, Desoye G. Effects of the synthetic glucocorticoid triamcinolone acetonide on vasoactive hydrolases of the human placenta in vitro. Placenta. 15:1994;377-388.
9. Hakkola J, Pasanen M, Hukkanen J, Pelkonen O, Mäenpää J, Edwards RJ, Boobis AR, Raunio H. Expression of xenobiotic-metabolizing cytochrome P450 forms in human full-term placenta. Biochem Pharmacol. 51:1996;403-411.
10. Hakkola J, Pelkonen O, Pasanen M, Raunio H. Xenobiotic-metabolizing cytochrome P450 enzymes in the human feto-placental unit: role in intrauterine toxicity. Crit Rev Toxicol. 28:1998;35-72.
11. Hakkola J, Raunio H, Purkunen R, Pelkonen O, Saarikoski S, Cresteil T, Pasanen M. Detection of cytochrome P450 gene expression in human placenta at first trimester of pregnancy. Biochem Pharmacol. 52:1996;379-383.
12. Hirvioja M-L, Tuimala R, Vuori J. The treatment of intrahepatic cholestasis of pregnancy by dexamethasone. Br J Obstet Gynaecol. 99:1992;109-111.
13. Honkakoski P, Lang MA. Mouse liver phenobarbital-inducible P450 system: purification, characterization and differential inducibility of four cytochrome P450 isozymes from D2 mouse. Arch Biochem Biophys. 273:1989;42-57.
14. Jobe AH, Wada N, Berry LM, Ikegami M, Erving MG. Single and repetitive maternal glucocorticoid exposures reduce fetal growth in sheep. Am J Obstet Gynaecol. 178:1998;880-885.
15. Kitawaki J, Inoue S, Tamura T, Yamamoto T, Nogushi T, Osawa Y, Okada H. Increasing aromatase cytochrome P-450 level in human placenta during pregnancy: studied by immunohistochemistry and enzyme-linked immunosorbent assay. Endocrinology. 130:1992;2751-1757.
16. Mulder EJ, Derks JB, Visser GH. Antenatal corticosteroid therapy and fetal behaviour: a randomised study of the effects of betamethasone and dexamethasone. Br J Obstet Gynaecol. 104:1997;1239-1247.
17. Nestler JE. Insulin-like growth factor II is a potent inhibitor of the aromatase activity of human placental cytotrophoblasts. Endocrinology. 127:1990;2064-2070.
18. Pasanen M. Human placental aromatase activity: use of a C18 reversed-phase cartridge for separation of tritiated water or steroid metabolites in placentas from both smoking and non-smoking mothers in vitro. Biological Research in Pregnancy. 6:1985;94-99.
19. Pasanen M, Haaparanta T, Sundin M, Sivonen P, Vähäkangas K, Raunio H, Hines R, Gustafsson J-Å, Pelkonen O. Immunochemical and molecular biochemical studies on human placental cigarette smoke-inducible cytochrome P-450-dependent monooxygenase activities. Toxicology. 62:1990;175-187.
20. Pasanen M, Helin-Martikainen H-L, Pelkonen O, Kirkinen P. Intrahepatic cholestasis of pregnancy impairs the activities of human placental xenobiotic and steroid metabolizing enzymes in vitro. Placenta. 18:1997;37-41.
21. Pasanen M, Pelkonen O. Solubilization and partial purification of human placental cytochromes P-450. Biochem Biophys Res Comm. 103:1981;1310-1317.
22. Pasanen M, Pelkonen O. Xenobiotic and steroid-metabolizing monooxygenases catalyzed by cytochrome P450 and glutathione Stransferase conjugations in the human placenta and their relationships to maternal cigarette smoking. Placenta. 11:1990;75-85.
23. Pasanen M, Pelkonen O. The expression and environmental regulation of P450 enzymes in human placenta. Crit Rev Toxicol. 24:1994;211-229.
24. Pasanen M, Raunio H, Pelkonen O. Freezing affects the activity and subcellular distribution profile of placental xenobiotic- and steroid-metabolizing enzymes. Placenta. 6:1985;527-535.
25. Rosen T, Krikun G, Ma Yh, Wang EY, Lockwood CJ, Guller S. Chronic antagonism of nuclear factor-kappa B activity in cytotrophoblasts by dexamethasone: A potential mechanism for antiinflammatory action of glucocorticoids in human placenta. J Clin Endocrinol Metab. 83:1998;3647-6352.
26. Senat MV, Minoui S, Multon O, Fernandez H, Frydman R, Ville Y. Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labor: a randomised study. Br J Obstet Gynaecol. 105:1998;749-755.
27. Shedlofsky SI, Israel BC, McClain CJ, Hill DB, Blouin RA. Endotoxin administration to humans inhibits hepatic cytochrome P450-mediated drug metabolism. J Clin Invest. 94:1994;2209-2214.
28. Simpson ER, Evans CT, Corbin CJ, Powell FE, Ledesma DB, Mendelson CR. Sequencing of cDNA inserts encoding aromatase cytochrome P-450 (P-450 arom). Mol Cell Endocrinol. 52:1987;267-272.
29. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. Measurement of protein using bicinchronic acid. Anal Biochem. 150:1985;76-85.
30. Toda K, Simpson ER, Mendelson CR, Shizuta Y, Kilgore MW. Expression of the gene encoding aromatase cytochrome P450 (CYP19) in fetal tissues. Mol Endocrinol. 8:1994;210-217.
31. Toma Y, Higashiyama T, Yarborough C, Osawa Y. Diverse functions of aromatase: O-deethylation of 7-ethoxycoumarin. Endocrinology. 137:1996;3791-3796.
32. Waxman DJ, Ko A, Walsh C. Regioselectivity and stereoselectivity of androgen hydroxylations catalyzed by cytochrome P-450 isozymes purified from phenobarbital-induced rat liver. J Biol Chem. 258:1983;11 937-11 947.